Stay updated on Chemo +/- Nivolumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Chemo +/- Nivolumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Chemo +/- Nivolumab in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the study record remains inaccessible with a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-11-03T21:20:10.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from the term “Artificial Intelligence” to “Super Intelligence,” and the site revision changes to v3.7.2. The study record itself still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-20T21:56:56.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T21:53:37.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error, with a minimal header and a Home link, replacing the usual study content and indicating restricted access to this record.
    Difference
    20%
    Check dated 2026-09-22T23:24:51.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.6.6 to v3.7.0, indicating a newer version of the page. This change affects only metadata and does not modify the study details or enrollment information.
    Difference
    0.0%
    Check dated 2026-09-15T23:37:21.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.5 to v3.6.6, signaling a new release of the page template. The update appears to be a maintenance or formatting change rather than a modification to the study data or details.
    Difference
    0.0%
    Check dated 2026-09-01T18:32:04.000Z thumbnail image

Stay in the know with updates to Chemo +/- Nivolumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Chemo +/- Nivolumab in NSCLC Clinical Trial page.